Search Results - "OʼToole, Dermot"

Endoscopic management of subepithelial lesions including neuroendocrine neoplasms: European Society of Gastrointestinal Endoscopy (ESGE) Guideline by Deprez, Pierre H, Moons, Leon M G, OʼToole, Dermot, Gincul, Rodica, Seicean, Andrada, Pimentel-Nunes, Pedro, Fernández-Esparrach, Gloria, Polkowski, Marcin, Vieth, Michael, Borbath, Ivan, Moreels, Tom G, Nieveen van Dijkum, Els, Blay, Jean-Yves, van Hooft, Jeanin E

“…1: ESGE recommends endoscopic ultrasonography (EUS) as the best tool to characterize subepithelial lesion (SEL) features (size, location, originating layer,…”
Get more information

ENETS standardized (synoptic) reporting in neuroendocrine tumours by Herder, Wouter W., Fazio, Nicola, O’Toole, Dermot

Get full text

Expanding Role of Gastroenterology in the Staging of Digestive Neuroendocrine Tumors: Updates From the American Joint Committee on Cancer Version 9 Cancer Staging System by Ge, Phillip S., Shi, Chanjuan, Asare, Elliot, Washington, Mary Kay, O’Toole, Dermot

Get full text

Consensus on molecular imaging and theranostics in neuroendocrine neoplasms by Ambrosini, Valentina, Kunikowska, Jolanta, Baudin, Eric, Bodei, Lisa, Bouvier, Catherine, Capdevila, Jaume, Cremonesi, Marta, de Herder, Wouter W., Dromain, Clarisse, Falconi, Massimo, Fani, Melpomeni, Fanti, Stefano, Hicks, Rodney J., Kabasakal, Levent, Kaltsas, Gregory, Lewington, Val, Minozzi, Silvia, Cinquini, Michela, Öberg, Kjell, Oyen, Wim. J.G., O'Toole, Dermot, Pavel, Marianne, Ruszniewski, Philippe, Scarpa, Aldo, Strosberg, Jonathan, Sundin, Anders, Taïeb, David, Virgolini, Irene, Wild, Damian, Herrmann, Ken, Yao, James

“…Nuclear medicine plays an increasingly important role in the management neuroendocrine neoplasms (NEN). Somatostatin analogue (SSA)-based positron emission…”
Get full text

ENETS standardized (synoptic) reporting for radiological imaging in neuroendocrine tumours by Dromain, Clarisse, Vullierme, Marie‐Pierre, Hicks, Rodney J., Prasad, Vikas, O’Toole, Dermot, Herder, Wouter W., Pavel, Marianne, Faggiano, Antongiulio, Kos‐Kudla, Beata, Öberg, Kjell, Krejs, Guenter J., Grande, Enrique, Niederle, Bruno, Sundin, Anders

“…This expert consensus document represents an initiative by the European Neuroendocrine Tumor Society (ENETS) to provide guidance for synoptic reporting of…”
Get full text

Radiofrequency Ablation for Neuroendocrine Liver Metastases: A Systematic Review by Mohan, Helen, MRCSI, Nicholson, Patrick, MRCSI, Winter, Des C., MD, O’Shea, Donal, MD, O’Toole, Dermot, MD, Geoghegan, Justin, FRCSI, Maguire, Donal, FRCSI, Hoti, Emir, FRCSEd, Traynor, Oscar, FRCSI, Cantwell, Colin P., MD

“…Abstract To determine the efficacy of radiofrequency (RF) ablation in neuroendocrine tumor (NET) liver metastases. A systematic review was performed following…”
Get full text

ENETS standardized (synoptic) reporting for molecular imaging studies in neuroendocrine tumours by Hicks, Rodney J., Dromain, Clarisse, Herder, Wouter W., Costa, Frederico P., Deroose, Christophe M., Frilling, Andrea, Koumarianou, Anna, Krenning, Eric P., Raymond, Eric, Bodei, Lisa, Sorbye, Halfdan, Welin, Staffan, Wiedenmann, Bertram, Wild, Damian, Howe, James R., Yao, James, O’Toole, Dermot, Sundin, Anders, Prasad, Vikas

“…The European Neuroendocrine Tumor Society (ENETS) promotes practices and procedures that aim to improve the standard of care delivered to patients diagnosed…”
Get full text

Pathology Reporting of Neuroendocrine Tumors: Application of the Delphic Consensus Process to the Development of a Minimum Pathology Data Set by KLIMSTRA, David S, MODLIN, Irvin R, MORAN, Cesar, MOSS, Steven F, OBERG, Kjell, O'TOOLE, Dermot, RINDI, Guido, ROBERT, Marie E, SUSTER, Saul, TANG, Laura H, TZEN, Chin-Yuan, WASHINGTON, Mary Kay, VOLKAN ADSAY, N, WIEDENMANN, Betram, YAO, James, CHETTY, Runjan, DESHPANDE, Vikram, GÖNEN, Mithat, JENSEN, Robert T, KIDD, Mark, KULKE, Matthew H, LLOYD, Ricardo V

“…Epithelial neuroendocrine tumors (NETs) have been the subject of much debate regarding their optimal classification. Although multiple systems of nomenclature,…”
Get full text

Multiple Endocrine Neoplasia Type 1 and the Pancreas: Diagnosis and Treatment of Functioning and Non-Functioning Pancreatic and Duodenal Neuroendocrine Neoplasia within the MEN1 Syndrome - An International Consensus Statement by Niederle, Bruno, Selberherr, Andreas, Bartsch, Detlef K, Brandi, Maria L, Doherty, Gerard M, Falconi, Massimo, Goudet, Pierre, Halfdanarson, Thorvardur R, Ito, Tetsuhide, Jensen, Robert T, Larghi, Alberto, Lee, Lingaku, Öberg, Kjell, Pavel, Marianne, Perren, Aurel, Sadowski, Samira M, Tonelli, Francesco, Triponez, Frédéric, Valk, Gerlof D, O'Toole, Dermot, Scott-Coombes, David, Thakker, Rajesh V, Thompson, Geoffrey B, Treglia, Giorgio, Wiedenmann, Bertram

“…The better understanding of the biological behavior of multiple endocrine neoplasia type 1 (MEN1) organ manifestations and the increase in clinical experience…”
Get more information

Radiofrequency ablation for low-grade dysplasia in Barrett’s esophagus: long-term outcome of a randomized trial by Pouw, Roos E., Klaver, Esther, Phoa, K. Nadine, van Vilsteren, Frederike G., Weusten, Bas L., Bisschops, Raf, Schoon, Erik .J., Pech, Oliver, Manner, Hendrik, Ragunath, Krish, Fernández-Sordo, Jacobo Ortiz, Fullarton, Grant, Di Pietro, Massimiliano, Januszewicz, Wladyslaw, O’Toole, Dermot, Bergman, Jacques J.

“…A prior randomized study (Surveillance versus Radiofrequency Ablation study [SURF study]) demonstrated that radiofrequency ablation (RFA) of Barrett's…”
Get full text

Real-time metabolic profiling of oesophageal tumours reveals an altered metabolic phenotype to different oxygen tensions and to treatment with Pyrazinib by Buckley, Amy M., Dunne, Margaret R., Morrissey, Maria E., Kennedy, Susan A., Nolan, Aoife, Davern, Maria, Foley, Emma K., Clarke, Niamh, Lysaght, Joanne, Ravi, Narayanasamy, O’Toole, Dermot, MacCarthy, Finbar, Reynolds, John V., Kennedy, Breandán N., O’Sullivan, Jacintha

“…Oesophageal cancer is the 6th most common cause of cancer related death worldwide. The current standard of care for oesophageal adenocarcinoma (OAC) focuses on…”
Get full text

Diagnosis and Management of Upper Gastrointestinal Neuroendocrine Tumors by Chin, Jun Liong, O'Toole, Dermot

“…Upper gastrointestinal neuroendocrine tumors (NETs) are rare tumors which are increasingly recognised by practising endoscopists. After confirmation by…”
Get full text

Differential Expression Profiles of Oxidative Stress Levels, 8-oxo-dG and 4-HNE, in Barrett's Esophagus Compared to Esophageal Adenocarcinoma by O'Farrell, Naoimh J, Phelan, James J, Feighery, Ronan, Doyle, Brendan, Picardo, Sarah L, Ravi, Narayanasamy, O'Toole, Dermot, Reynolds, John V, O'Sullivan, Jacintha

“…Barrett's esophagus (BE), a chronic inflammatory condition, is the leading risk factor for esophageal adenocarcinoma (EAC). In inflammation to cancer pathways,…”
Get full text

Evidence for the Positive Impact of Centralization in Esophageal Cancer Surgery by Donlon, Noel E, Moran, Brendan, Davern, Maria, Davey, Matthew G, Kennedy, Czara, Leahy, Roisin, Moore, Jenny, King, Sinead, Lowery, Maeve, Cunningham, Moya, Donohoe, Claire L, O'Toole, Dermot, Ravi, Narayanasamy, Reynolds, John V

“…In this study we analyzed the impact of centralization on key metrics, outcomes and patterns of care at the Irish National Center. Overall survival rates in…”
Get full text

Outcomes for Esophageal Squamous Cell Carcinoma Treated with Curative Intent in a Western Cohort: Should Multimodal Therapy Be the Gold Standard? by Sheil, Fiachra, Donohoe, Claire L., King, Sinéad, O’Toole, Dermot, Cunningham, Moya, Cuffe, Sinéad, Ravi, Narayanasamy, Reynolds, John V.

“…Introduction The standard of care for treatment of oesophageal squamous cell carcinoma (SCC) continues to evolve. Neoadjuvant chemoradiotherapy (neoCRT)…”
Get full text

Characterizing caspase-1 involvement during esophageal disease progression by Barber, Gillian, Anand, Akanksha, Katarzyna Oficjalska, Phelan, James J., Heeran, Aisling B., Flis, Ewelina, Clarke, Niamh E., Watson, Jenny A., Strangmann, Julia, Flood, Brian, O’Neill, Hazel, O’Toole, Dermot, MacCarthy, Finbar, Ravi, Narayanasamy, Reynolds, John V., Kay, Elaine W., Quante, Michael, O’Sullivan, Jacintha, Creagh, Emma M.

“…Barrett’s esophagus (BE) is an inflammatory condition and a neoplastic precursor to esophageal adenocarcinoma (EAC). Inflammasome signaling, which contributes…”
Get full text

Critical updates in neuroendocrine tumors: Version 9 American Joint Committee on Cancer staging system for gastroenteropancreatic neuroendocrine tumors by Chauhan, Aman, Chan, Kelley, Halfdanarson, Thorvardur R., Bellizzi, Andrew M., Rindi, Guido, O’Toole, Dermot, Ge, Phillip S., Jain, Dhanpat, Dasari, Arvind, Anaya, Daniel A., Bergsland, Emily, Mittra, Erik, Wei, Alice C., Hope, Thomas A., Kendi, Ayse T., Thomas, Samantha M., Flem, Sherlonda, Brierley, James, Asare, Elliot A., Washington, Kay, Shi, Chanjuan

“…The American Joint Committee on Cancer (AJCC) staging system for all cancer sites, including gastroenteropancreatic neuroendocrine tumors (GEP‐NETs), is meant…”
Get full text

PRESTO 2: An International Survey to Evaluate Patients’ Injection Experiences with the Latest Devices/Formulations of Long-Acting Somatostatin Analog Therapies for Neuroendocrine Tumors or Acromegaly by O’Toole, Dermot, Kunz, Pamela L., Webb, Susan M., Goldstein, Grace, Khawaja, Sheila, McDonnell, Mark, Boiziau, Sandra, Gueguen, Delphine, Houchard, Aude, Ribeiro-Oliveira, Antonio, Prebtani, Ally

“…Introduction Real-world data evaluating patients’ injection experiences using the latest devices/formulations of the long-acting (LA) somatostatin analogs…”
Get full text

Bevacizumab combined with 5-FU/streptozocin in patients with progressive metastatic well-differentiated pancreatic endocrine tumours (BETTER trial) – A phase II non-randomised trial by Ducreux, Michel, Dahan, Laetitia, Smith, Denis, O’Toole, Dermot, Lepère, Céline, Dromain, Clarisse, Vilgrain, Valérie, Baudin, Eric, Lombard-Bohas, Catherine, Scoazec, Jean-Yves, Seitz, Jean-François, Bitoun, Laurence, Koné, Sébastien, Mitry, Emmanuel

“…Abstract Aim of the study Neuroendocrine tumours are highly vascular neoplasms known to overexpress vascular endothelial growth factor (VEGF) and its receptor…”
Get full text

Correction to: PRESTO 2: An International Survey to Evaluate Patients’ Injection Experiences with the Latest Devices/Formulations of Long-Acting Somatostatin Analog Therapies for Neuroendocrine Tumors or Acromegaly by O’Toole, Dermot, Kunz, Pamela L., Webb, Susan M., Goldstein, Grace, Khawaja, Sheila, McDonnell, Mark, Boiziau, Sandra, Gueguen, Delphine, Houchard, Aude, Ribeiro-Oliveira, Antonio, Prebtani, Ally

Get full text